SpectraScience: Innovations in Cancer Detection

SpectraScience has developed patented platform technology that diagnoses colorectal cancer, which has a market size of $1, 442.6 million.

Read more »

OneMedForum Recap: Del Mar Pharmaceuticals

Delmar Pharmaceuticals (DMPI) is a clinical and early stage Oncologyl Company focused on developing and commercializing leading anti-cancer therapies in high impact orphan oncological indications specifically where patients have failed contemporary therapy.

Read more »

OneMedForum Recap: Pressure Biosciences

Pressure Biosciences (PBIO) is a life sciences company centered on developing and commercializing a novel technology titled Pressure Cycling Technology (PCT).

Read more »

The Fly on the Wall: Athersys Publishes Study on Increasing Survival of Organ Transplants With Stem Cells

Athersys (ATHX) is a clinical stage based biopharmaceutical company with an exponentially growing pipeline and an array of products in therapeutics to treat significant and life-threatening diseases.

Read more »

PR Newswire: BioDelivery Sciences International Secures $20 Million in Debt Financing

A company to keep a look out for in the upcoming future is BioDelivery Sciences International (BDSI), a specialty pharmaceutical company with a platform of drug delivery technologies to develop, commercialize, and improve already proven applications of therapeutics.

Read more »

Global News Wire: Pluristem Therapeutics Forms Strategic Alliance with ChaBio & Diostech

Pluristem Therapeutics (PSTI) is a developer of placenta-based cell therapies. They have just formed a strategic alliance with Cha Bio&Diostech.

Read more »

Global News Wire: Novavax Initiating Human Clinical Trials for H7N9 Virus

Novavax, Inc (NVAX) is a clinical-stage biopharmaceutical company that strives to create novel vaccines to treat a broad spectrum of diseases around the world.

Read more »

Pharma Live: Cytokinetics amending errors in Amyotrophic Lateral Sclerosis Phase IIB Study

Cytokinetics (CYTK) is a clinical stage biotechnology company that focuses on the discovery and development of novel molecular therapeutics in relation to muscle function.

Read more »

BioCentury: Orexo is Dissolving Away Opioid Addiction with New Medication

Orexo is an emerging specialty pharmaceutical company in route to enter the market with their new medication Zubsolv; an oral medication that dissolves under the tongue to treat opioid addiction.

Read more »

Associated Press: Omeros Corporation — Award Winning Drug OMS824 Being Tested to Treat Huntington’s & Schizophrenia

Omeros Corporation (OMER) will soon begin two mid stage clinical trials on its drug OMS824 which has greatly increased its stock prices. The company is testing its drug as a treatment for Huntington’s disease toward the end of 2013 as well as trials involved the treatment of Schizophrenia.

Read more »